Lipid profiles and outcomes of patients with prior cancer and subsequent myocardial infarction or stroke

• Published in: Scientific reports Vol. 11; no. 1; p. 21167
• Main Authors: Koo, Chieh Yang, Zheng, Huili, Tan, Li Ling, Foo, Ling-Li, Seet, Raymond, Chong, Jun-Hua, Hausenloy, Derek J., Chng, Wee-Joo, Richards, A. Mark, Lee, Chi-Hang, Chan, Mark Y.
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 27.10.2021; Nature Publishing Group; Nature Portfolio
• Subjects: 692/4019; 692/4028/67; 692/499; Aged; Aged, 80 and over; Cancer; Cardiometabolic Risk Factors; Cerebral infarction; Cholesterol; Cholesterol - blood; Female; Heart attacks; Humanities and Social Sciences; Humans; Lipids; Low density lipoprotein; Male; Mortality; multidisciplinary; Myocardial infarction; Myocardial Infarction - blood; Myocardial Infarction - epidemiology; Neoplasms - blood; Neoplasms - epidemiology; Science; Science (multidisciplinary); Stroke; Stroke - blood; Stroke - epidemiology; Triglycerides - blood
• ISSN: 2045-2322; 2045-2322
• DOI: 10.1038/s41598-021-00666-z

Patients with cancer are at increased risk of myocardial infarction (MI) and stroke. Guidelines do not address lipid profile targets for these patients. Within the lipid profiles, we hypothesized that patients with cancer develop MI or stroke at lower low density lipoprotein cholesterol (LDL-C) concentrations than patients without cancer and suffer worse outcomes. We linked nationwide longitudinal MI, stroke and cancer registries from years 2007–2017. We identified 42,148 eligible patients with MI (2421 prior cancer; 39,727 no cancer) and 43,888 eligible patients with stroke (3152 prior cancer; 40,738 no cancer). Median LDL-C concentration was lower in the prior cancer group than the no cancer group at incident MI [2.43 versus 3.10 mmol/L, adjusted ratio 0.87 (95% CI 0.85–0.89)] and stroke [2.81 versus 3.22 mmol/L, adjusted ratio 0.93, 95% CI 0.91–0.95)]. Similarly, median triglyceride and total cholesterol concentrations were lower in the prior cancer group, with no difference in high density lipoprotein cholesterol. Prior cancer was associated with higher post-MI mortality [adjusted hazard ratio (HR) 1.48, 95% CI 1.37–1.59] and post-stroke mortality (adjusted HR 1.95, 95% CI 1.52–2.52). Despite lower LDL-C concentrations, patients with prior cancer had worse post-MI and stroke mortality than patients without cancer.